BioneXt LAB Coronavirus SARS-CoV-2 Information

The PCR screening performed on a nasopharyngeal swab allows the presence of the SARS-CoV-2 coronavirus responsible for COVID-19 to be diagnosed reliably. This test is performed on prescription and is paid for by the CNS.

The serological test is used to detect the presence in the blood of antibodies produced by the immune system following an infection with SARS-CoV-2 (COVID-19). In certain situations, it can help diagnose an acute infection. It is also used to detect a previous infection. 

Consult our SARS-CoV-2 Serology FAQs 

CoVive is a CE-certified support and monitoring app (class 1 medical device) developed in response to the SARS-CoV-2 (COVID-19) pandemic.

CoVive provides you with clear information on your state of health, while at the same time offering you self-assessment and self-monitoring functions, as well as explanations of your test results. The app acts as a reassuring companion, a source of reliable information guiding you in all decisions regarding your health.

Just answer a few questions and the CoVive app 

● will issue a recommendation on the need to seek medical assistance in line with the symptoms described 
● will provide you with information on where to have your tests performed and may possibly put you in contact with a local health professional 
● will help you interpret the results of your tests

CoVive has a monitoring function which tracks such vital signs as temperature as well as your clinical signs. The app can also notify local healthcare facilities if necessary.

Contact: covive@bionext.lu

In line with government guidelines, the eConsult platform allows online consultations with your doctor.

(Click here to download the patient tutorial).

The purpose of CON-VINCE, the COvid-19 National survey for assessing VIral spread by Non-affected CarriErs conducted by the LIH (Luxembourg Institute of Health – www.lih.lu) in cooperation with the University of Luxembourg (www.uni.lu), the LCSB (Luxembourg Centre for Systems Biomedicine-www.lcsb.lu) and the IBBL (Integrated Biobank of Luxembourg – www.ibbl.lu)  is to understand the prevalence of the COVID-19 (SARS-CoV2) infection in the Luxembourgish population so as to assess:

• the psychological impact of the lockdown, and 
• the spread of the virus and the immune status (presence of antibodies) of citizens 

so as to define an exit strategy and a gradual lifting of the lockdown. 

As a partner in this study, the BioneXt LAB makes it human and technical resources available to test the participants who have been selected at the national level by the TNS-ILRES  institute (www.tns-ilres.com) and to conduct analyses. 

Have you been selected for this survey and received a questionnaire to complete with a voucher for the samples to be taken indicating the date and time of your appointment? 

1. You can go to the head office of the BioneXt LAB to undergo the procedure for your samples. 
2. You can call the Pickendoheem mobile service for a sampling at home if you are unable to travel.